This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Beijing Dongfang Biotech Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Hua Tu: Innovator in Diabetes and Obesity Treatment
Introduction
Hua Tu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of treatments for diabetes and obesity. His innovative work has led to the creation of a unique fusion protein that holds promise for improving patient outcomes.
Latest Patents
Hua Tu holds a patent for a fusion protein of Exendin-4 and its analog, along with its preparation method and use. This fusion protein is obtained by fusing Exendin-4 or its analog to the Fc region of human IgG2 via a linking peptide. The resulting product exhibits better stability and a prolonged serum half-life, making it a valuable option for treating diabetes and obesity.
Career Highlights
Hua Tu is associated with Beijing Dongfang Biotech Co., Ltd., where he continues to advance his research and development efforts. His work has garnered attention in the scientific community, contributing to the understanding and treatment of metabolic disorders.
Collaborations
Hua Tu collaborates with notable colleagues, including Xianhong Bai and Xianzhong Li. Their combined expertise enhances the research and development initiatives at their company.
Conclusion
Hua Tu's innovative contributions to biotechnology, particularly in the realm of diabetes and obesity treatment, highlight his role as a leading inventor. His patented fusion protein represents a significant advancement in therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile